Dr Lotti Tajouri is one of Australia's leading researchers in the field of molecular genetics. Having undertaken his Bachelor and Masters level degrees in France, he completed his PhD thesis in molecular genetics at Griffith University, funded by a prestigious Lindsay Yeo Research Scholarship. His research has examined gene profiling in a range of medical conditions, including breast cancer, multiple sclerosis, rheumatoid arthritis, leukaemia and migraines; resulting in numerous published articles and conference presentations.
Articles
Adrenoceptor function and expression in bladder urothelium and lamina propria (with Christian Moro and Russ Chess-Williams), Urology (2012)
Objective - To investigate the role of adrenoceptor subtypes in regulating the spontaneous contractile activity...
Assessment of immune function after short-term administration of recombinant human growth hormone in healthy young males (with Sandra B. Ramos, Ekua W. Brenu, Rhys Christy, A. Bon Gray, Lars McNaughton, Mieke Van Driel, and Sonya M. Marshall-Gradisnik), European journal of applied physiology (2011)
Growth hormone (GH) is a commonly used drug aimed at improving sport performance. The aim...
Investigation of the [-/A]8 and C1236T genetic variations within the human toll-like receptor 3 gene for association with multiple sclerosis (with Attila L. Szvetko, Ashleigh Jones, Jason Mackenzie, Peter A. Csurhes, Judith M. Greer, Michael Pender, and Lyn Griffiths), Neurological research (2010)
Multiple sclerosis (MS) is a serious cause of neurological disability among young adults. The clinical...
Study of leukemia inhibitory factor polymorphism within an Australian multiple sclerosis population (with Jason Mackenzie, Attila Szvetko, Verena Weth, Julie Moreau, Judith M. Greer, Peter A. Csurhes, Michael P. Pender, and Lyn R. Griffiths), Study of leukemia inhibitory factor polymorphism within an Australian multiple sclerosis population (2009)
Objective: To examine a polymorphism within the 3′ untranslated region of the leukemia inhibitory factor...
An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population (with Attila L. Szvetko, Ashleigh Jones, Jason Mackenzie, Peter A. Csurhes, Judith M. Greer, Michael P. Pender, and Lyn R. Griffiths), Brain research (2009)
Multiple sclerosis (MS) is a common cause of neurological disability in young adults. The disease...
Book Chapters
Vasoactive neuropeptides in autoimmune diseases (with Ekua W. Brenu, Donald R. Staines, and Sonya M. Marshall-Gradisnik), Autoimmune disorders - Current concepts and advances from bedside to mechanistic insights (2011)
Extract:
Neuropeptides are a class of regulatory peptides with effects in nearly all physiological systems and...
Mechanism of autoimmunity in pregnancy - The good and the bad (with Ekua W. Brenu, Donald R. Staines, and Sonya M. Marshall-Gradisnik), Autoimmune disorders - Pathogenetic aspects (2011)
Extract:
In humans, female’s humoral and cellular immunity are actually stronger than men (Nalbandian & Kovats,...
Immunomodulators as therapeutic strategies for managing Multiple Sclerosis (with Ekua W. Brenu, Donald R. Staines, and Sonya Marshall-Gradisnik), Autoimmune disorders: Symptoms, diagnosis and treatment (2011)
Immunomodulation and immunosuppression are important strategies for monitoring autoimmune disorders. As imbalances in immune function...